{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:40:07Z","timestamp":1781800807678,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.bbrc.2010.10.023","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T10:47:13Z","timestamp":1286794033000},"page":"312-318","source":"Crossref","is-referenced-by-count":57,"title":["Gene disruption of caspase-3 prevents MPTP-induced Parkinson\u2019s disease in mice"],"prefix":"10.1016","volume":"402","author":[{"given":"Marina","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willington","family":"Amutuhaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumito","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kaneki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.bbrc.2010.10.023_b0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"255","author":"Alves","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbrc.2010.10.023_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","article-title":"Pathogenic role of glial cells in Parkinson\u2019s disease","volume":"18","author":"Teismann","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2010.10.023_b0015","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2010.10.023_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2000.7489","article-title":"Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson\u2019s disease","volume":"166","author":"Tatton","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2010.10.023_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007020050001","article-title":"Cell death mechanisms in Parkinson\u2019s disease","volume":"107","author":"Jellinger","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbrc.2010.10.023_b0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0022-510X(95)00336-Z","article-title":"Histochemical detection of apoptosis in Parkinson\u2019s disease","volume":"137","author":"Mochizuki","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrc.2010.10.023_b0035","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1002\/ana.410440721","article-title":"A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson\u2019s disease","volume":"44","author":"Tatton","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2010.10.023_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-7091-6842-4_13","article-title":"Apoptosis in neurodegenerative disorders","volume":"Suppl. 50","author":"Mochizuki","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbrc.2010.10.023_b0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.870130604","article-title":"DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?","volume":"13","author":"Kingsbury","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2010.10.023_b0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s004010051005","article-title":"Cell death and apoptosis regulating proteins in Parkinson\u2019s disease\u2013a cautionary note","volume":"97","author":"Wullner","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2010.10.023_b0055","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2010.10.023_b0060","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.10.023_b0065","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.21-24-09519.2001","article-title":"Caspase-9 activation results in downstream caspase-8 activation bid cleavage in 1-methyl-4-phenyl-1,3,2,6-tetrahydropyridine-induced Parkinson\u2019s disease","volume":"21","author":"Viswanath","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2010.10.023_b0070","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1523\/JNEUROSCI.21-07-02247.2001","article-title":"Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease but pathway inhibition results in neuronal necrosis","volume":"21","author":"Hartmann","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2010.10.023_b0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mds.1037","article-title":"Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice","volume":"16","author":"Turmel","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2010.10.023_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(96)12323-5","article-title":"Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,3,6-tetrahydropyridine (MPTP) treatment of mice","volume":"204","author":"Hassouna","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2010.10.023_b0085","doi-asserted-by":"crossref","first-page":"34451","DOI":"10.1074\/jbc.M202099200","article-title":"The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes","volume":"277","author":"Serra","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.10.023_b0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-12,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2010.10.023_b0095","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","article-title":"Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"98","author":"Vila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2010.10.023_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuroscience.2006.02.007","article-title":"Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid model of Parkinson\u2019s disease","volume":"140","author":"Novikova","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2010.10.023_b0105","first-page":"649","article-title":"TUNEL-positive cells in the substantia nigra of C57BL\/6 mice after a single bolus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"85","author":"Spooren","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2010.10.023_b0110","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1523\/JNEUROSCI.3309-03.2004","article-title":"Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"24","author":"Furuya","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2010.10.023_b0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nbd.2004.07.021","article-title":"A novel systemically active caspase inhibitor attenuates the toxicities of MPTP malonate and 3NP in vivo","volume":"17","author":"Yang","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2010.10.023_b0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0306-4522(98)00154-7","article-title":"Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons","volume":"86","author":"Dodel","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2010.10.023_b0125","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1046\/j.1460-9568.2003.02864.x","article-title":"Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration","volume":"18","author":"Kaul","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2010.10.023_b0130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1097-4547(20010301)63:5<421::AID-JNR1037>3.0.CO;2-4","article-title":"Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells","volume":"63","author":"Gomez","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2010.10.023_b0135","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E","article-title":"Two distinct mechanisms are involved in 6-hydroxydopamine-MPP+induced dopaminergic neuronal cell death: role of caspases ROS and JNK","volume":"57","author":"Choi","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrc.2010.10.023_b0140","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1523\/JNEUROSCI.23-12-05069.2003","article-title":"Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment","volume":"23","author":"Han","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2010.10.023_b0145","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1471-4159.2005.03329.x","article-title":"Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells","volume":"94","author":"Chu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2010.10.023_b0150","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1101\/gad.12.6.806","article-title":"Essential contribution of caspase 3\/CPP32 to apoptosis and its associated nuclear changes","volume":"12","author":"Woo","year":"1998","journal-title":"Genes. Dev."},{"key":"10.1016\/j.bbrc.2010.10.023_b0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2010.10.023_b0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2008.105","article-title":"Amyloid-beta causes memory impairment by disturbing the JAK2\/STAT3 axis in hippocampal neurons","volume":"14","author":"Chiba","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbrc.2010.10.023_b0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10571-007-9241-2","article-title":"Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice","volume":"28","author":"Oki","year":"2008","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2010.10.023_b0170","doi-asserted-by":"crossref","unstructured":"L. Frau, F. Borsini, J. Wardas, A.S. Khairnar, N. Schintu, M. Morelli, Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson\u2019s disease, Synapse, (2010).","DOI":"10.1002\/syn.20833"},{"key":"10.1016\/j.bbrc.2010.10.023_b0175","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.10.023_b0205","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bbrc.2009.12.094","article-title":"Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice","volume":"391","author":"Shinozaki","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.10.023_b0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neures.2004.11.008","article-title":"Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL\/6 mice","volume":"51","author":"Mori","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbrc.2010.10.023_b0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson\u2019s disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2010.10.023_b0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","article-title":"Cellular pathology of Parkinson\u2019s disease: astrocytes microglia and inflammation","volume":"318","author":"Teismann","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2010.10.023_b0200","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000","article-title":"Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"20","author":"Eberhardt","year":"2000","journal-title":"J. Neurosci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10018747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10018747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T07:11:06Z","timestamp":1559718666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X10018747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0006291X10018747"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.10.023","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}